Focus on China Market Research
¼òÌåÖÐÎÄ
|
ENGLISH
Home
|
About CCMR
About CCMR
Value Propositions
Our Team
Organize Framework
Methods
|
Research Services
Branding Research
Communications Research
Competitive Intelligence Research
Market Opportunity Research
Product Development Research
Satisfaction and loyalty Research
Segmentation Research
U&A Research
|
References
Projects by Industry
Projects by Research
|
Clients
Aerospace
Automotive
Chemicals
Construction
Education
Energy and Utilities
Engineering
Finacial Services
Food and Drink
Government /Publlic Sector
Healthcare
IT /Technology
Manufacturing /Industrial
Media /Advertising
Oil and Gas
Professional Services
Paper,Print and Packaging
Retail and Consumer
Telecommunications
Transport and Logistics
|
Contacts
Contact
Online Message
|
Views
Goods & General & Manufacturing
Technology And Media
Life Sciences
|
Join us
Work at CCMR
Life Sciences
Home
>>
Views
>>
Life Sciences
The Phoenix Healthcare Group is to become the fist Chinese hospital going pubic listed
Source£º
CCMR
Data£º2013-11-15
The Phoenix Healthcare Group is planning to go public listed in HK stock market in 18
th
of this month. As the first hospital being public listed in China, the Phoenix intends to raise about $200 million.
Related Hot
¡¤Report on 2012 China' s Registered Tumor Patient
¡¤Chinese Healthcare Spending
¡¤Monthly Output of Chinese Patent Medicine, Jan.2011-Oct.2012
¡¤Fairwood (HKG:0052) repurchases 41K shares
¡¤Interchina (HKG:0202) places shares for $359M
¡¤Venturepharm (HKG:8225) to halt trading for results release
¡¤Wuyi Pharma (HKG:1889) 2011 net profit RMB57M, down 46%; div HK$0.008
¡¤Lijun (HKG:2005) sinks to red, 2011 NL $41M; div 2 ct
¡¤Healthy Living
¡¤BMS Banks on Innovative Drugs to Double China Sales
¡¤Genetic Technologies executes agreement with Eurofins STA
¡¤Takeda announces establishment of development center in China
¡¤Roche supports animal conservation research
¡¤Fudan-Zhangjiang (HKG:8231) Sees 2011 Net Profit Up Sharply
¡¤IDT acquires 1st BASE oligonucleotide business
¡¤BioDiem licenses LAIV technology to Changchun BCHT
Views
Goods & General & Manufacturing
Technology And Media
Life Sciences
Research Services
Branding Research
Communications Research
Competitive Intelligence Research
Market Opportunity Research
Product Development Research
Satisfaction and loyalty Research
Segmentation Research
U&A Research
¦ò
more
Link£º
Bindu
|
csxxc
|
Logistics
|
XSTHGJG
|
HNDTMP
|
HNHFHB
|
CSDYWT
|
ÔÁICP±¸13082131ºÅ
|
Copyright © 2012-2020 CCMR | China Ceidea Market Research Co., LTD Inc. All rights reserved.
Add£ºRoom 406 Huide Building No 102 Hao Xian Road Yuexiu District Guangzhou Tel£º+86-020-28931413 +86 13503051005
BINWEB